Novartis posts profit gain thanks to new drugs (Update)
(AP)—Swiss pharmaceutical company Novartis AG reported a 6.7 percent increase in profit for the first quarter Wednesday, boosted by new products and emerging markets.
Medications
Apr 24, 2013 |
not rated yet |
0
India's rejection of drug patent could reverberate
The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world's largest drugmakers. ...
Medications
Apr 01, 2013 |
not rated yet |
0
Drug maker Novartis loses India patent battle (Update)
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world ...
Medications
Apr 01, 2013 |
5 / 5 (3) |
0
India's top court to deliver Novartis judgment
India's Supreme Court is to rule Monday on a landmark patent case involving Swiss drugmaker Novartis AG that focuses on demands by major companies that their investments be protected, against Indian companies ...
Medications
Mar 31, 2013 |
not rated yet |
0
Novartis Q4 net profit rebounds to $2.1 billion
(AP)—Swiss drug maker Novartis AG reported a jump in fourth-quarter net profit to $2.08 billion on Wednesday, citing the lack of a $900-million one-time charge it took in the same period the previous year.
Other
Jan 23, 2013 |
not rated yet |
0
Indian court to rule on generic drug industry
(AP)—From Africa's crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging in the balance ahead of a legal ruling that will ...
Medications
Jan 04, 2013 |
not rated yet |
0
EU drug regulator OKs Novartis' meningitis B shot
Europe's top drug regulator has recommended approval for the first vaccine against meningitis B, made by Novartis AG.
Medications
Nov 16, 2012 |
not rated yet |
0
EU approves Novartis-Incyte blood cancer drug
Novartis AG and Incyte Corp. said Tuesday that European Union regulators approved their blood cancer drug Jakavi.
Medications
Sep 04, 2012 |
not rated yet |
0
Novartis drug investigated after 11 deaths
A multiple sclerosis drug made by industry giant Novartis is under investigation after at least 11 patients taking the medicine died.
Medications
Jan 20, 2012 |
5 / 5 (1) |
0
Study: Bone drug boosts breast cancer survival
(AP) -- Doctors were mostly hoping to prevent complications and relapses when they gave young women a medicine to keep their bones strong during breast cancer treatment. Seven years later, they found it did more than that: ...
Cancer
Dec 09, 2011 |
not rated yet |
0
Big promise is seen in 2 new breast cancer drugs
(AP) -- Breast cancer experts are cheering what could be some of the biggest advances in more than a decade: two new medicines that significantly delay the time until women with very advanced cases get worse.
Cancer
Dec 08, 2011 |
not rated yet |
0
Novartis fights patent rejection in Indian court
(AP) -- In a case that could affect India's role as drug provider to the developing world, the Supreme Court began hearing arguments Tuesday over whether the government had the right to deny a patent to Swiss drugmaker Novartis ...
Medications
Sep 06, 2011 |
5 / 5 (3) |
0
